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Objective. n-3 long-chain polyunsaturated fatty acids (LCPUFAs) have shown potential to increase lipid oxidation and prevent
obesity. Subjects. Seventy-eight boys aged 13–15 y with whole-body fat% of 30 ± 9% were randomly assigned to consume bread
with fish oil (FO) (1.5 g n-3 LCPUFA/d) or vegetable oil for 16 weeks. All boys were counselled to improve diet and exercise habits.
Results. Lifestyle counselling resulted in decreased sugar intake but did not change the physical activity level. Whole-body fat%
decreased 0.7± 2.5% and 0.6± 2.2%, resting metabolic rate after the intervention was 7150 ± 1134 kJ/d versus 7150± 1042 kJ/d,
and the respiratory quotient was 0.89 ± 0.05 versus 0.88 ± 0.05, in the FO and control group, respectively. No group diﬀerences
were significant. Conclusion. FO-supplementation to slightly overweight teenage boys did not result in beneficial eﬀects on RMR,
lipid oxidation, or body composition.
1. Introduction
Results from rodent studies have showed that dietary n-3
long-chain polyunsaturated fatty acids (LCPUFAs) increase
fat oxidation and prevent high fat and sugar-induced obesity
[1, 2]. Human studies have indicated similar eﬀects of fish oil.
A study by Couet et al. with healthy adults [3] and a study by
Kabir et al. with diabetic women [4] both showed reduced
body fat mass after fish oil interventions that lasted 3 weeks
and 2 month, respectively. Hill et al., however, found no
eﬀect of fish oil on fat mass in a group of overweight subjects
[5], but they and others [5–7] found that inclusion of fish oil
in a hypocaloric diet increased weight loss.
Nakatani et al. found that fish oil supplementation in-
creased the expression of uncoupling protein 2 (UCP-2)
in rodent hepatocytes, which could explain the observed
protection from weight gain [8]. Tsuboyama-Kasaoka et al.
later used a UCP-2 knock out model to show that dietary
fish oil prevents weight gain in rodents even in the absence
of UCP-2, suggesting more than one pathway in mediating
the eﬀects of fish oil on weight control [9]. n-3 LCPUFAs
have been shown to increase adiponectin concentrations in
rodents and obese humans [10], and as adiponectin has been
shown to increase fatty acid oxidation [11], this could also
be a mechanism for the alleged antiadiposity eﬀects of n-3
LCPUFAs.
Considering the association between childhood obesity
and later lifestyle diseases [12], early prevention of over-
weight and its sequelae is important. Studies on how children
and adolescents respond to dietary interventions are few, and
since it is problematic to extrapolate the results from inter-
ventions with adult subjects, data from intervention-studies
in children are much needed. Therefore, we have investigated
if n-3 LCPUFAs increase lipid oxidation, and improve body
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composition in slightly overweight teenage boys during their
pubertal growth spurt.
2. Materials andMethods
2.1. Study Population. The study protocol was approved by
The Committees on Biomedical Research Ethics of the Capi-
tol Region of Denmark (H-A-2007-0055) and registered in
the Clinical Trials database (http://www.clinicaltrials.gov/
no.NCT00929552). The recruitment and inclusion criteria
have been previously described [13]. Our inclusion criteria
were body mass for height above the 90th percentile and
the average BMI of the included boys was comparable to
25 kg/m2 for adults [14].
2.2. Study Design and Intervention. The participants were
randomly assigned to dietary supplementation with fish oil
(FO) or a control oil blend for a 16-week intervention. The
oils were included in bread, and the participants were
asked to consume two pieces of rye bread and one wheat
roll pr day. The intervention bread was produced for this
study by Kohberg A/S (Bolderslev, Denmark). The fish
oil was microencapsulated tuna oil from NuMega (Clover
Corporation, Sydney, NSW, Australia), and the control oil
was a 6 : 1 : 1 mix of palm shortening, soy oil, and rapeseed
oil. We designed the study to provide the FO-group with
1.5 g/d LCPUFAs, which was the dose shown by Couet et
al. to increase fat oxidation in adults [3]. However, random
sampling of the bread revealed that the fat content was
lower, providing the FO-group 4.9 (4.1–5.4) g/d (0.2 g/d
eicosapentaenoic acid (EPA) + 0.9 g/d docosahexaenoic acid
(DHA)) and 4.2 (3.0–5.0) g/d in the control group. (See full
fatty acid composition in the bread in [13].) Both subjects
and investigators were blinded to the treatment. Biomedical
measurements were taken at baseline and after 16 weeks of
intervention.
2.3. Life Style Intervention. The participants in this study
were also subjected to a life style intervention, as we tried to
educate and influence the boys towards healthier diets and
a higher level of physical activity. Subjects in both groups
received counselling by a dietician at the first examination
visit and were further encouraged and supported in making
healthy choices (regarding diet and exercise) every two
weeks when they came in to pick up new supplies of
bread. The initial counselling was based on a four-day food
diary, including three weekdays and one weekend day, and
results from a seven-day step recording with a pedometer
(Yamax SW-200 Tokyo, Japan). The details about these re-
cordings were published elsewhere [13].
2.4. Anthropometry, Body Composition, and Indirect
Calorimetry. The boys were measured in the morning after
an overnight fast. Height was measured to nearest cm, and
weight to nearest 100 g on an electronic scale (Frederiksberg
Vægtfabrik, Frederiksberg, Denmark). A measuring tape was
used for waist and hip circumferences. Waist circumference
was measured right below the ribs, and hip circumference
was measured at the fullest part of the hip. Body composition
was assessed by DXA scanning (Prodigy, General Electric
Company, Madison, WI, USA). The scanner was calibrated
each morning before use. Analysis of all scans was performed
using enCore 2008 software (General Electric Company).
Resting metabolic rate (RMR) and respiratory quotient
(RQ) was measured by indirect calorimetry in a ventilated
hood (Viasys Healthcare, Hoechberg, Germany). Metabolic
testing was performed after 15min supine of rest, and lasted
for 25min, of which the first 5min were omitted from the
later calculations. The calorimeters used room air for ventila-
tion and for comparison with exhaust gas, and the analyzers
were therefore calibrated to room air before each use and
every 5min during testing. Analyzers were furthermore
calibrated to a standard gas sample (Air Liquide Danmark,
Taastrup, Denmark) every day and tested every week with
controlled alcohol burns. All readings were subsequently
adjusted according to the results from the alcohol burn test.
2.5. Blood Sampling. Blood samples for the analysis of red
blood cell (RBC) fatty acid composition, plasma adipokines
and growth markers were drawn from the antecubital vein.
The blood for RBC fatty acid analysis was collected in
lithium-heparin-coated tubes, EDTA-coated tubes were used
for analysis of leptin and adiponectin, and uncoated tubes
for testosterone, insulin-like growth factor-1 (IGF-1), and
insulin-like growth factor binding protein-3 (IGFBP-3).
Blood samples were immediately placed on ice before cen-
trifugation at 4◦C with 2500 g for 10min to isolate plasma,
which was stored at −80◦C until later analysis. RBCs were
washed three times in isotonic saline and finally reconstituted
1 : 1 with isotonic saline with 0.005% butylated hydroxy-
toluene, and stored under nitrogen at −80◦C.
2.6. Biochemical Analyses. Adiponectin was analyzed with a
Milipore RIA kit (cat no. HADP-61HK, Billerica, MA, USA),
and leptin was analyzed with a Human leptin RIA kit (cat no.
HL-81K, Linco, St Charles, MO, USA). Interassay CV% was
<9% for both adiponectin and leptin, and quality controls
in both assays fell within expected limits. Testosterone, IGF-
1, and IGFBP-3 concentrations were measured using an
Immulite 1000 and kits from Siemens Medical Solutions
Diagnostics (Los Angeles, CA, US). All CV%on the Immulite
was <9%. The fatty acid composition in RBCwas determined
as previously described [14].
2.7. Statistical Analysis. Values are reported as mean ± SD if
the data follow a normal distribution and as geometric mean
(95% CI) if the data are not normally distributed. Potential
eﬀects of the intervention were analyzed using SAS 9.1 (SAS
Institute Inc., Cary, NC, USA) with general linear models
to adjust for the eﬀect of covariates (ANCOVA). Baseline
values of the outcome measure in question were included as
covariate in all tests. Change in testosterone was furthermore
included as covariate in the group comparisons of whole
body fat percentage (fat-%), trunk fat-%, fat mass, hip and
waist circumferences, and waist/hip ratio. The ANCOVA
residuals were plotted to assess the need for transformation
of the dependent variable. Within group changes from
baseline to followup were assessed by paired t-tests. The
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study was based on power calculations to make it possible to
show significant diﬀerences in the magnitude of 0.4 SD with
α = 0.05 and β = 0.20 in a 2-sided test.
3. Results
The intervention was completed by 78 of the 87 teenage boys
who originally entered the study. Six subjects dropped out
from the FO-group and 3 from the control group. Reasons
for withdrawal were: disliking the taste of the bread (5 from
the FO-group and 2 from the control group), and insuﬃcient
structure in meal habits, which prevented them from eating
the daily ration of bread (1 from each group). When asked
after completion, 48% of the boys in the control group and
73% of the boys in the FO-group were able to guess which
diet they had received. Compliance, estimated by asking the
boys how much of the bread they had eaten during the
intervention, was about 90% (70–100%) in both groups.
Baseline measurements showed that the boys were
successfully randomized with respect to anthropometric
measures and habitual diet (Table 1). During the 16-
week intervention, the boys grew in height (1.8 ± 1.2 cm)
and weight (2.0 ± 2.6 kg), and there was a significant
increase in plasma testosterone of 0.6 ± 1.0 μg/L. These
developmental changes were similar for both groups. The
lifestyle counselling resulted in a significant reduction in
sugar intake and an increase in fibre intake for both groups.
The boys in the FO-group significantly reduced fat intake
compared with baseline, but the change was not diﬀerent
from that in the control group. No further diﬀerences were
observed in the energy intake, the overall macronutrient
composition of the diet, or the level of physical activity (steps
per day).
The two groups had similar RBC fatty acid composition
at baseline, but the RBC fatty acid composition at the end of
the intervention period reflected that of the intervention oils
(See [13]). In summary, DHA and EPA had increased by 78
and 100%, respectively, (DHA from 3.9 to 6.7 and EPA from
0.6 to 1.2% of total fatty acids) in the FO-group and by 14
and 20%, respectively, in the control group.
Whole body fat-% was significantly reduced in all boys
after the intervention (P < 0.02), but no change was seen
for the trunk fat-%. There was, however, no eﬀect of fish
oil on body composition compared with the control group
(Table 2). No group diﬀerences were seen for hip and waist
circumference, or the waist to hip ratio and RMR and RQ
were also unaﬀected by the treatments.
Leptin tended to decrease for the whole group (P = 0.06),
and the change was best explained by the change in weight
(r2 = 0.138, P < 0.001), but the correlation with changes
in fat mass was also significant (r2 = 0.056, P < 0.04).
Changes in adiponectin concentration correlated directly
with the change in fat mass (r2 = 0.061, P < 0.03). No
group diﬀerences were found (Table 3), but there was a weak,
but significant, inverse correlation between the change in
the RBC-content of DHA+EPA and plasma concentrations
of adiponectin at the end of the intervention adjusted for
baseline values and changes in fat mass (Figure 1).
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Figure 1: The correlation between the change in DHA+EPA con-
tent of RBC and plasma adiponectin at the end of the intervention
adjusted for baseline values and changes in fat mass.
4. Discussion
In the present study, we did not find an eﬀect of fish oil
supplementation on metabolic rate and body composition
in slightly overweight boys during puberty growth, nor did
our results indicate any eﬀect on fat oxidation as RQ was
similar in the groups. These results on adolescent boys
are in contradiction to the results from Couet et al., who
found reduced RQ (suggesting increased lipid oxidation),
and reduced fat mass in adults after only three weeks of fish
oil intervention with doses only slightly higher than what we
used [3], but in line with a recently published study from
DeFina et al. who studied the eﬀect of n-3 PUFA intake in
combination with diet and excercise. In present study, the oil
was a DHA-rich tuna oil, which resulted in a higher average
DHA intake than what was attained by Couet and colleagues
(0.9 versus 0.7 g/d). Thus, the lack of eﬀect in present study
cannot be explained by a too low DHA intake. It is also
noteworthy that DeFina et al. used an EPA-rich oil at a
higher level of intake than in our study (3 g/d of EPA+DHA)
without observing eﬀect on weight, metabolic rate, or RQ
beyond those achieved with diet and exercise alone [16]. The
weight reducing eﬀect of fish oil has been consistent in rodent
studies. However, most of the rodent studies have used high
doses of fish oil. Nakatani et al. investigated the eﬀects of
diﬀerent fish oil doses in female C57BL/6J mice and found
that less than 40 E% fish oil was insuﬃcient in reducing
weight-gain [17]. Setting up a similar experiment to find the
minimumdose for an eﬀect onmetabolism in humans would
be highly interesting and may prove that the dose used in this
study was too low for an eﬀect to be detected. However, if the
results parallel those in mice, that much fish oil is unrealistic
in a human context, and using fish oil in weight management
could be futile.
Because childhood obesity has long-lasting consequen-
ces, it is important to investigate potential health eﬀects of
commonly used foodstuﬀ in children and adolescents. It
is diﬃcult to compare our results with studies in adults,
as adolescents are not, metabolically, in a steady state, and
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Table 1: Anthropometrics, habitual diet, and exercise1.
Baseline 16 weeks
Control n = 40 Fish oil n = 38 Control n = 40 Fish oil n = 38 P2
Anthropometrics
Age (yrs) 14.3 ± 0.6 14.3 ± 0.7 14.6 ± 0.6 14.6 ± 0.7
Weight (kg) 66.6 ± 9.9 69.8 ± 14.3 68.7 ± 10.3∗3 71.7 ± 14.4∗ 0.73
Height (cm) 169 ± 9 169 ± 11 171 ± 9∗ 170 ± 11∗ 0.45
BMI (kg/m2)4 23.1 (22.5–23.7) 24.1 (23.1–25.2) 23.3 (22.7–23.9) 24.3 (23.3–25.4)∗ 0.81
Testosterone (μg/L) 3.0 ± 1.7 3.5 ± 1.7 3.6 ± 2.0∗ 4.0 ± 1.8∗ 0.48
IGF-1 360 ± 101 333 ± 93 352 ± 84 363 ± 86 0.19
IGFBP-3 5.5 ± 0.9 5.4 ± 0.6 5.4 ± 0.8 5.4 ± 0.6 0.08
Habitual diet
Energy intake (kJ) 9292 ± 2523 8716 ± 2811 8524 ± 2258 8043 ± 2631 0.89
Carbohydrates (E%) 50.7 ± 5.1 51.3 ± 5.0 52.0 ± 6.7 52.7 ± 5.8 0.90
Protein (E%) 15.3 ± 2.9 15.5 ± 2.7 15.1 ± 2.9 16.2 ± 2.6 0.22
Fat (E%)5 33.8 ± 4.7 33.3 ± 5.3 32.9 ± 6.4 31.0 ± 5.7∗ 0.19
SFA (E%) 14.0 ± 2.4 14.0 ± 2.8 13.7 ± 3.3 12.8 ± 3.0∗ 0.21
MUFA (E%) 12.2 ± 2.2 11.6 ± 2.2 11.7 ± 2.6 10.9 ± 2.3∗ 0.56
PUFA (E%) 5.2 ± 1.2 5.2 ± 1.0 5.1 ± 1.3 4.9 ± 1.1 0.43
n-3 PUFA (E%) 0.3 ± 0.2 0.3 ± 0.2 0.3 ± 0.2 0.2 ± 0.2 0.51
Added sugar (E%) 10.8 ± 5.5 9.0 ± 5.0 8.6 ± 4.9∗ 6.7 ± 4.7∗ 0.98
Fibre (g/MJ) 1.9 ± 0.5 2.1 ± 0.6 2.2 ± 0.5∗ 2.5 ± 0.7∗ 0.16
Physical activity
Steps pr day 10 950 ± 3842 10 711 ± 4253 11 901 ± 4234 11 134 ± 5395 0.43
1
Data are presented as mean ± SD or geometric mean (95% CI).
2P values for baseline adjusted group diﬀerences at 16 weeks.
3∗Indicates that the within-group-change from baseline to followup is significant (P < 0.05), assessed by paired t-tests.
4The usual cut-oﬀs for BMI (>25 kg/m2 = overweight) is not applicable to children. The corresponding value for 13–15-year-old boys lies between 21.9 and
23.6 kg/m2 [15].
5This table compares habitual fat intake only, that is not including the contribution of energy and fat from supplemental oils.
Table 2: Metabolic rate and body composition1.
Baseline 16 weeks
Control n = 40 Fish oil n = 38 Control n = 40 Fish oil n = 38 P2
RMR (kJ/d) 6974 ± 913 7032 ± 1067 7150 ± 1134 7150 ± 1042 0.703
RQ 0.88 ± 0.06 0.89 ± 0.07 0.89 ± 0.05 0.88 ± 0.05 0.623
Whole body fat (%) 28.5 ± 8.8 31.1 ± 8.1 27.8 ± 8.8 30.5 ± 7.7 0.67
Trunk fat (%) 31.5 ± 9.5 31.7 ± 8.8 31.4 ± 9.2 31.1 ± 8.8 0.45
Fat mass (kg) 18.9 ± 6.2 21.9 ± 8.1 18.9 ± 6.1 22.1 ± 7.9 0.63
Hip circumference (cm) 94.9 ± 5.6 96.5 ± 8.3 95.9 ± 6.2 97.4 ± 8.7 0.94
Waist circumference (cm) 81.0 ± 6.4 83.1 ± 10.7 81.5 ± 6.0 83.0 ± 9.7 0.83
Waist/Hip 0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 0.88
1
Data are presented as mean ± SD.
2P values describe group diﬀerences at 16 weeks adjusted for baseline and Δ testosterone.
3The analysis of RMR and RQ was only adjusted for baseline values.
Table 3: Plasma concentrations of adipokines1.
Baseline 16 weeks
Control n = 40 Fish oil n = 38 Control n = 40 Fish oil n = 38 P2
Leptin (ng/mL) 7.6 (5.8–9.9) 7.4 (5.7–9.7) 7.2 (5.6–9.2) 6.9 (6.8–9.9) 0.99
Adiponectin (μg/mL) 8.7 (7.3–10.4) 8.0 (6.7–9.6) 7.9 (6.4–9.5) 8.2 (6.8–10.0) 0.49
1
Data are presented as geometric mean (95% CI).
2P values describe group diﬀerences at 16 weeks adjusted for baseline and Δ fat mass.
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changes in body composition in particular are controlled by
mechanisms other than those seen in adults. Compared with
the study of Couet et al. they had the advantage of a cross over
design [3], which we were unable to match considering the
unsteady state of our participants. The unsteady state might
have increased the variation in the measurements due to
diﬀerences in the pubertal development, which was a factor
we tried adjusting for by including delta testosterone levels as
covariate in most analyses. We, furthermore, studied a much
larger group for a longer duration of time, which added
to the quality of our study. It should be noted that the n-
3 LCPUFAs in this study were included in bread and not
given as pure oil. In one study the metabolic response to
n-3 LCPUFAs was diﬀerent when given as a salmon enriched
diet compared with capsule supplementation, suggesting
a possible matrix eﬀect [18]. However, another study showed
similar incorporation of n-3 LCPUFAs from capsules and
fatty fish [19]. Unfortunately, we did not reach our intended
dose of fish oil (1.5 g/d as in Couet et al. [3]), and we saw
a slightly higher fat content of the bread in the FO-group,
which may have counteracted a potential beneficial eﬀect
of the fish oil supplement. The diﬀerence in total fat intake
caused by this might have been counter balanced somewhat
as we also saw a significant reduction in dietary fat intake
between baseline and follow up in the FO-group only.
In our design, we tried to influence the participants to
change lifestyle, which was included primarily for ethical
reasons. The lifestyle intervention had no impact on the
physical activity level, but sugar consumption had decreased
for both groups, indicating that participation in the study
had increased the boys’ awareness of candy and soft drink
usage. Fiber consumption was also increased during the
intervention, but this is likely attributed to the fiber-rich
bread provided by us, and not a lasting change in eating
habits. The limited success of the lifestyle intervention shows
that making a change in the most obvious bad habits is
easier than making a commitment to increasing the physical
activity level in spite of continuous encouragement to do so.
The lifestyle intervention could have increased variation in
the outcomemeasures ormight have been a design advantage
as previous studies have indicated that the eﬀects of dietary
fish oil was augmented when combined with increased
exercise or reduced caloric intake [5–7]. There is also the risk
that decreased sugar and increased fiber consumption had an
impact on the outcome measures overriding that of the fish
oil intervention.
Circulating leptin was reduced in a study with rats fed
fish oil [20], but a human intervention study by Mori
et al. showed no reduction after fish oil supplementation
[21]. This agrees with our results as no group diﬀerences
were found after 16 weeks of fish oil consumption. Leptin
is a marker of adiposity [22], and plasma concentration
of leptin has been shown to correlate with fat mass [22].
In our data, changes in leptin concentration correlated
more strongly with changes in total body weight than with
the changes in fat mass. n-3 LCPUFAs has been shown
to increase adiponectin concentrations in rodents and obese
humans [10]. In the present study, fish oil supplementation
did not lead to an increase in adiponectin concentration,
rather on the contrary, as we found a weak yet significant
inverse association between the change in the RBC-content
of EPA+DHA and changes in adiponectin concentration.
Plasma concentrations of adiponectin have been shown to
correlate inversely with fat mass [23], but in the present study
changes in adiponectin concentration correlated directly
with changes in fat mass. In a previous study in pubertal boys
and girls, Schoppen et al. also did not find a significant cor-
relation between plasma adiponectin and fat mass or fat%.
However, they did find higher adiponectin levels in normal
weight girls compared with overweight or obese girls, but
this relationship was not seen for boys [24]. Thus, diﬀerence
between our results and those from previous studies could
be due to the male puberty, which was shown by Andersen
et al. to aﬀect adiponectin levels [25]. Girls experience
metabolic and hormonal changes during adolescence that
are very diﬀerent from the male developments and might
therefore respond diﬀerently to a similar treatment. The
boys in this study were healthy and only mildly overweight,
and it is not known if obese boys with more pronounced
metabolic complications would respond diﬀerently to a fish
oil intervention.
In conclusion, a 16-week fish oil intervention did not
influence RMR or body composition in slightly overweight
boys during their puberty growth spurt compared with the
eﬀect of a vegetable control oil. The antiobesity eﬀect of n-3
LCPUFAs in adults has not been consistent, and more work
is needed to investigate diﬀerences in the response to n-3
LCPUFAs in adolescents compared with adults.
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